home · filing · 0001171843-25-002238
8-K
filed April 16, 2025, 7:59 PM ET
ticker HBIO
CIK 0001123494
leadership
confidence high
sentiment neutral
materiality 0.40
Harvard Bioscience director Bertrand Loy not standing for re-election at 2025 annual meeting
HARVARD BIOSCIENCE INC
Bertrand Loy informed company April 10, 2025, he will not stand for re-election at the 2025 Annual Meeting.
Loy has served on the Board since 2014; currently Lead Independent Director and member of Audit and Nominating & Governance committees.
Decision not due to any disagreement with company's operations, policies, or practices; Loy continues as director until the meeting.
Board expressed appreciation for Loy's service.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Filed April 16, 2025, 7:59 PM ET
On April 10, 2025, Bertrand Loy informed the Company that he will not stand for re-election at the Company’s 2025 Annual Meeting.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 1.0
Bertrand Loy departed as Lead Independent Director at HARVARD BIOSCIENCE INC.
Action will not stand for re-election
Role Lead Independent Director
Exact text from the filing
On April 10, 2025, Bertrand Loy informed the Company that he will not stand for re-election at the Company’s 2025 Annual Meeting.
View on SEC.gov
Source: SEC EDGAR
accession 0001171843-25-002238
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.